Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

Oral semaglutide led to significant reductions in the risk for heart failure and major adverse cardiac events (MACEs) among patients with type 2 diabetes (T2D) with a history of heart failure, a ...

GLP-1-class weight-loss drugs can help users shed dozens of pounds, leading to a more active, energized life. One in eight ...

A recent post hoc analysis published the Journal of the American Medical Association revealed oral semaglutide to show early and sustained improvements in multiple atherosclerotic ...

Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...

Once-weekly semaglutide 1 mg improved multiple cardiometabolic measures in patients with type 1 diabetes and may reduce long-term cardiovascular disease risk, according to a presenter. As Healio ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other ...

New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy.

Durability through 156 weeks favored semaglutide for HbA1c (−0.47%), weight (−3.26%), systolic BP (−1.83 mm Hg), and pulse ...

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, ...